Archive | Oral Cancer News RSS feed for this section

Checkpoint inhibitors seen to show potential of immunotherapy in several cancer studies

4. May 2016

0 Comments

Source: immuno-oncologynews.com Author: Magdalena Kegel Several new checkpoint inhibitors — a class of immunotherapy drugs used in cancer — continue to show beneficial effects in numerous cancer types, according to data presented at the recent American Association for Cancer Research Annual Meeting in New Orleans. Investigated checkpoint inhibitors confirmed earlier results showing evidence of efficacy […]

Continue reading...

HPV vaccination rates for boys in Nova Scotia climbing, province says

4. May 2016

0 Comments

Source: www.cbc.ca Author: Jon Tattrie, CBC News Nova Scotia has one of the best HPV vaccination rates in the country with boys getting the vaccine at the same rate as girls, the province’s chief public health officer says. In 2008, Nova Scotia started offering the vaccine to Grade 7 girls to protect against cancer. In […]

Continue reading...

Baidu Under Investigation After Cancer Patient’s Death

3. May 2016

0 Comments

Source: www.fortune.com Author: Scott Cendrowski   Baidu, the dominant search engine in China, is being investigated by government regulators after social media users criticized the quality of medical ads appearing in its searches. Chinese social media over the weekend gave widespread exposure to the story of Wei Zexi, a young cancer patient whose family pooled […]

Continue reading...

Researchers link hepatitis C virus to head and neck cancers

27. April 2016

0 Comments

Source: lymphomanewstoday.com Author: Magdalena Kegel A study from The University of Texas MD Anderson Cancer Center shows the hepatitis C infection, previously linked to liver cancer and non-Hodgkin’s lymphoma, is associated with cancers of the head and neck — a finding that could have immediate implications in how hepatitis-infected patients are screened, and how head […]

Continue reading...

BMS gets US breakthrough status for head & neck cancer

27. April 2016

0 Comments

Source: pharmatimes.com Author: Selina McKee US regulators have awarded Bristol-Myers Squibb’s immunotherapy Opdivo a breakthrough designation for the potential indication of recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). The move, which should help expedite the drug’s development and review, comes after preliminary clinical evidence indicated it could offer a substantial […]

Continue reading...

Drug Target in Rare, Lethal Glandular Cancer Discovered

21. April 2016

0 Comments

Source: www.dddmag.com Author: Yale University   Using a novel cell culture approach, Yale Cancer Center researchers have discovered critical vulnerabilities in adenoid cystic carcinoma (ACC), a rare and lethal glandular cancer with a high recurrence rate and few treatment options. The findings, published April 15th in the journal Clinical Cancer Research, offer data that ACC […]

Continue reading...

FDA Spends $36 Million on Anti-Chewing Tobacco Ad Campaign

21. April 2016

0 Comments

Source: www.freebeacon.com Author: Elizabeth Harrington The Food and Drug Administration is spending $36 million on an anti-chewing tobacco advertising campaign targeted at white male teenagers in the midwest. The federal agency announced Tuesday it is expanding its “Real Cost” anti-tobacco campaign to “educate rural, white male teenagers” and convince them to stop dipping. “Smokeless tobacco […]

Continue reading...

Chemotherapy + radiation may improve survival for some elderly

19. April 2016

0 Comments

Source: journals.lww.com Author: Carlson, Robert H., Oncology Times Because the toxicity of concurrent chemoradiation is greater than radiation therapy alone for definitive head and neck cancer treatment, many clinicians have reservations about offering chemoradiotherapy for elderly head and neck cancer patients. But a new study shows that combining chemotherapy with radiation therapy improves survival rates […]

Continue reading...

Hepatitis C Virus strongly linked to head and neck cancer: study

19. April 2016

0 Comments

Source: www.techtimes.com Author: Deepthi B, Tech Times People infected with the Hepatitis C virus (HCV), one of the most common blood-borne virus infections, are more prone to developing particular types of head and neck cancer, according to a new study. Researchers from the Univerity of Texas MD Anderson Cancer Center have revealed that HCV-infected people […]

Continue reading...

Nivolumab Improved Survival For Patients With Head and Neck Squamous Cell Carcinoma

19. April 2016

0 Comments

Source: www.aacr.org Author: AACR Newsroom Staff   NEW ORLEANS — Treatment with the immunotherapeutic nivolumab (Opdivo) improved survival for patients with recurrent or metastatic head and neck squamous cell carcinoma that progressed after platinum-based chemotherapy compared with single-agent chemotherapy of the investigator’s choice, according to results from the CheckMate-141 phase III clinical trial presented here […]

Continue reading...